These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 21723196

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fetal cardiocentesis in care of severe Kell immunisation.
    Bakos O, Ewald U, Lindgren PG.
    Fetal Diagn Ther; 1998; 13(6):372-4. PubMed ID: 9933822
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment of extremely severe fetal anemia due to anti-Jra alloimmunization.
    Ishihara Y, Miyata S, Chiba Y, Kawai T.
    Fetal Diagn Ther; 2006; 21(3):269-71. PubMed ID: 16601336
    [Abstract] [Full Text] [Related]

  • 4. An audit of outcome in intravascular transfusions using the intrahepatic portion of the fetal umbilical vein compared to cordocentesis.
    Somerset DA, Moore A, Whittle MJ, Martin W, Kilby MD.
    Fetal Diagn Ther; 2006; 21(3):272-6. PubMed ID: 16601337
    [Abstract] [Full Text] [Related]

  • 5. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
    Ree IMC, Lopriore E, Zwiers C, Böhringer S, Janssen MWM, Oepkes D, De Haas M.
    Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
    [Abstract] [Full Text] [Related]

  • 6. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.
    Al Riyami AZ, Al Salmani M, Al Hashami S, Al Mahrooqi S, Al Hinai S, Al Balushi H, Al Riyami N, Gowri V, Al Dughaishi T, Al Hosni S, Al-Khabori M, Al-Farsi K, Al Huneini M, Alkindi S.
    Transfusion; 2014 Jan; 54(1):238-43. PubMed ID: 23829228
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Therapeutic management of fetal anemia: review of standard practice and alternative treatment options.
    Papantoniou N, Sifakis S, Antsaklis A.
    J Perinat Med; 2013 Jan; 41(1):71-82. PubMed ID: 23093258
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Successful treatment of extremely severe fetal anemia due to Kell alloimmunization.
    Collinet P, Subtil D, Puech F, Vaast P.
    Obstet Gynecol; 2002 Nov; 100(5 Pt 2):1102-5. PubMed ID: 12423822
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Severe hemolytic disease of the newborn due to anti-Js(b).
    Gordon MC, Kennedy MS, O'Shaughnessy RW, Waheed A.
    Vox Sang; 1995 Nov; 69(2):140-1. PubMed ID: 8585197
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Implementation of routine screening for Kell antibodies: does it improve perinatal survival?
    Kamphuis MM, Lindenburg I, van Kamp IL, Meerman RH, Kanhai HH, Oepkes D.
    Transfusion; 2008 May; 48(5):953-7. PubMed ID: 18248569
    [Abstract] [Full Text] [Related]

  • 18. Intrauterine red cell transfusion for anti-Kell isoimmunization in a fetus with Glanzmann's thrombasthenia.
    Unterscheider J, Ryan H, Morrison JJ, Malone FD.
    Prenat Diagn; 2013 Nov; 33(11):1107-9. PubMed ID: 23861189
    [No Abstract] [Full Text] [Related]

  • 19. Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease.
    Kriplani A, Malhotra Singh B, Mandal K.
    Gynecol Obstet Invest; 2007 Nov; 63(3):176-80. PubMed ID: 17143009
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.